Dev Karan, PhD

Publications

• Racial differences in serum chemokines in prostate cancer patients.

  (Karan D, Wick J, Dubey S, Kumar-Sinha C, Siddiqui J, Kunju LP, Iczkowski KA, Chinnaiyan AM.) Cancer. 2023 Dec 01;129(23):3783-3789 PMID: 37698493 SCOPUS ID: 2-s2.0-85170696897 09/12/2023

• DNA Methyltransferase 1 Targeting Using Guadecitabine Inhibits Prostate Cancer Growth by an Apoptosis-Independent Pathway.

  (Karan D, Singh M, Dubey S, Van Veldhuizen PJ, Saunthararajah Y.) Cancers (Basel). 2023 May 15;15(10) PMID: 37345101 PMCID: PMC10216613 06/22/2023

• DNA Methyltransferase 1 Targeting Using Guadecitabine Inhibits Prostate Cancer Growth by an Apoptosis-Independent Pathway

  (Karan D, Singh M, Dubey S, Van Veldhuizen PJ, Saunthararajah Y.) Cancers. May 2023;15(10) SCOPUS ID: 2-s2.0-85160763012 05/01/2023

• RSK1 vs. RSK2 Inhibitory Activity of the Marine β-Carboline Alkaloid Manzamine A: A Biochemical, Cervical Cancer Protein Expression, and Computational Study.

  (Mayer AMS, Hall ML, Lach J, Clifford J, Chandrasena K, Canton C, Kontoyianni M, Choo YM, Karan D, Hamann MT.) Mar Drugs. 2021 Sep 07;19(9) PMID: 34564169 PMCID: PMC8467814 SCOPUS ID: 2-s2.0-85114615152 09/27/2021

• CCL23 in Balancing the Act of Endoplasmic Reticulum Stress and Antitumor Immunity in Hepatocellular Carcinoma.

  (Karan D.) Front Oncol. 2021;11:727583 PMID: 34671553 PMCID: PMC8522494 10/22/2021

• CCL23 in Balancing the Act of Endoplasmic Reticulum Stress and Antitumor Immunity in Hepatocellular Carcinoma

  (Karan D.) Frontiers in Oncology. 4 October 2021;11 SCOPUS ID: 2-s2.0-85117317725 10/04/2021

• A Perspective on Withania somnifera Modulating Antitumor Immunity in Targeting Prostate Cancer.

  (Dubey S, Singh M, Nelson A, Karan D.) J Immunol Res. 2021;2021:9483433 PMID: 34485538 PMCID: PMC8413038 SCOPUS ID: 2-s2.0-85114595038 09/07/2021

• RSK1 vs. RSK2 Inhibitory Activity of the Marine β-Carboline Alkaloid Manzamine A: A Biochemical, Cervical Cancer Protein Expression, and Computational Study

  (.) . 09/07/2021

• RSK1 vs. RSK2 inhibitory activity of the marine β-carboline alkaloid manzamine A: A biochemical, cervical cancer protein expression, and computational study

  (Mayer AMS, Hall ML, Lach J, Clifford J, Chandrasena K, Canton C, Kontoyianni M, Choo YM, Karan D, Hamann MT.) Marine Drugs. September 2021;19(9) SCOPUS ID: 2-s2.0-85114615152 09/01/2021

• Circulatory MIC-1 as a Determinant of Prostate Cancer Racial Disparity.

  (Karan D, Wick J, Dubey S, Tawfik O, Van Veldhuizen P.) Cancers (Basel). 2020 Oct 18;12(10) PMID: 33081054 PMCID: PMC7603134 10/22/2020

• The Marine Natural Product Manzamine A Inhibits Cervical Cancer by Targeting the SIX1 Protein.

  (Karan D, Dubey S, Pirisi L, Nagel A, Pina I, Choo YM, Hamann MT.) J Nat Prod. 2020 Feb 28;83(2):286-295 PMID: 32022559 PMCID: PMC7161578 SCOPUS ID: 2-s2.0-85079554428 02/06/2020

• Inflammasomes: Emerging Central Players in Cancer Immunology and Immunotherapy.

  (Karan D.) Front Immunol. 2018;9:3028 PMID: 30631327 PMCID: PMC6315184 SCOPUS ID: 2-s2.0-85059829126 01/12/2019